Spanish Suicide Crisis Inventory and Checklist for hospitalized adults in Chile

Suicidal Crisis Syndrome and the Suicide Crisis Inventory-Revised (SCS-2): Psychometric Properties of the Spanish Version

Observational University Diego Portales · NCT07103850

This project tests Spanish versions of two questionnaires (SCS-2 and SCS-C) to see if they can help identify imminent suicide risk in adults recently hospitalized for suicidal behavior.

Quick facts

Study typeObservational
Enrollment60 (estimated)
Ages18 Years and up
SexAll
SponsorUniversity Diego Portales Academic / other
Locations1 site (Santiago, Santiago Metropolitan)
Trial IDNCT07103850 on ClinicalTrials.gov

What this trial studies

This observational validation project translates and culturally adapts the SCS-2 and SCS-C into Spanish, pilots the items with a small group, then prospectively enrolls 60 adult psychiatric inpatients hospitalized for recent suicidal behavior at Complejo Asistencial Dr. Sótero del Río in Santiago. Participants complete the instruments at admission and discharge, and a subset repeats measures for test-retest and interrater reliability. The instruments' internal consistency and construct validity will be compared with established tools (MINI, Sheehan Disability Scale, and Sheehan Suicidality Tracking Scale), and outcomes at 7 and 30 days post-discharge will be tracked by phone and chart review. The study follows standard forward-backward translation, pilot testing, and psychometric analysis methods used for validating clinical questionnaires.

Who should consider this trial

Good fit: Adults (age ≥18) hospitalized at the Complejo Asistencial Dr. Sótero del Río UHCIP for a recent suicidal event who are fluent in Spanish, able to consent, and judged competent by their treating psychiatrist.

Not a fit: Patients with severe psychotic symptoms, altered consciousness (e.g., delirium), severe agitation needing mechanical restraint, significant cognitive impairment, or non-Spanish speakers are unlikely to benefit from these instruments as tested here.

Why it matters

Potential benefit: If successful, these Spanish tools could help clinicians detect imminent suicide risk more reliably and inform safer discharge planning.

How similar studies have performed: Related versions of the Suicide Crisis Inventory and checklist have shown promising psychometric results in other populations, but Spanish validation in Chilean inpatient settings is limited and this application is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Currently hospitalized in the Psychiatric Intensive Care Unit (UHCIP) at Complejo Asistencial Dr. Sótero del Río (CASR)
* Hospitalization due to a recent suicidal event, defined as at least one of the following:

  1. Deliberate self-inflicted violence with actual or potential injury and explicit or implicit suicidal intent
  2. Preparatory behaviors for suicide
  3. Aborted suicide attempts
  4. Interrupted suicide attempts
  5. Suicidal ideation leading to emergency consultation or referral
* Able to provide informed consent
* Judged competent to participate by the treating psychiatrist
* Fluent in Spanish

Exclusion Criteria:

* Presence of severe psychotic symptoms
* Qualitative or quantitative disturbance of consciousness (e.g., delirium, coma)
* Severe psychomotor agitation requiring mechanical restraint
* Inability to understand or complete study procedures (e.g., due to cognitive impairment or language barriers)

Where this trial is running

Santiago, Santiago Metropolitan

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Suicidal CrisisSuicidal Crisis Syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.